DEVELOPMENT OF RESISTANCE DURING ANTIBIOTIC-THERAPY

被引:143
作者
MILATOVIC, D
BRAVENY, I
机构
关键词
D O I
10.1007/BF02017607
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:234 / 244
页数:11
相关论文
共 74 条
[1]  
ACAR JF, 1971, POSTGRAD MED J, V47, P103
[2]   EMERGENCE OF CIPROFLOXACIN-RESISTANT PSEUDOMANAS-AERUGINOSA AFTER COMBINED THERAPY WITH CIPROFLOXACIN AND AMIKACIN [J].
AZADIAN, BS ;
BENDIG, JWA ;
SAMSON, DM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 (06) :771-771
[3]   CEFTRIAXONE THERAPY OF SERIOUS BACTERIAL-INFECTIONS IN ADULTS [J].
BITTNER, MJ ;
DWORZACK, DL ;
PREHEIM, LC ;
TOFTE, RW ;
CROSSLEY, KB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (02) :261-266
[4]   THE EFFICACY AND SAFETY OF CIPROFLOXACIN IN THE TREATMENT OF CHRONIC PSEUDOMONAS-AERUGINOSA URINARY-TRACT INFECTION [J].
BROWN, EM ;
MORRIS, R ;
STEPHENSON, TP .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 :123-127
[5]   COMPARISON OF THE ACTIVITY OF ANTIBIOTIC COMBINATIONS INVITRO WITH CLINICAL OUTCOME AND RESISTANCE EMERGENCE IN SERIOUS INFECTION BY PSEUDOMONAS-AERUGINOSA IN NON-NEUTROPENIC PATIENTS [J].
CHANDRASEKAR, PH ;
CRANE, LR ;
BAILEY, EJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1987, 19 (03) :321-329
[6]  
CHAPMAN ST, 1985, LANCET, V2, P39
[7]  
COLQUHOUN J, 1950, LANCET, V259, P621
[8]   AMIKACIN THERAPY OF PATIENTS WITH MULTIPLY ANTIBIOTIC-RESISTANT SERRATIA-MARCESCENS INFECTIONS - DEVELOPMENT OF INCREASING RESISTANCE DURING THERAPY [J].
CRAVEN, PC ;
JORGENSEN, JH ;
KASPAR, RL ;
DRUTZ, DJ .
AMERICAN JOURNAL OF MEDICINE, 1977, 62 (06) :902-909
[9]  
CROOK SM, 1985, LANCET, V1, P1275
[10]  
CULLMANN W, 1986, IMMUN INFEKT, V14, P227